Implementing the severe community-acquired pneumonia guidelines in low- and middle-income countries

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSALLUH, Jorge
dc.contributor.authorKAWANO-DOURADO, Leticia
dc.date.accessioned2024-04-05T19:41:25Z
dc.date.available2024-04-05T19:41:25Z
dc.date.issued2023
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexScopus
dc.description.indexDimensions
dc.description.indexWoS
dc.description.sponsorshipCNPq
dc.description.sponsorshipFAPERJ
dc.identifier.citationINTENSIVE CARE MEDICINE, v.49, n.11, p.1392-1396, 2023
dc.identifier.doi10.1007/s00134-023-07220-7
dc.identifier.eissn1432-1238
dc.identifier.issn0342-4642
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/59252
dc.language.isoeng
dc.publisherSPRINGEReng
dc.relation.ispartofIntensive Care Medicine
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright SPRINGEReng
dc.subject.wosCritical Care Medicineeng
dc.titleImplementing the severe community-acquired pneumonia guidelines in low- and middle-income countrieseng
dc.typearticleeng
dc.type.categoryeditorial materialeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalSALLUH, Jorge:DOr Inst Res & Educ IDOR, Dept Crit Care, Rua Diniz Cordeiro,30 3 Andar, BR-22281100 Rio De Janeiro, RJ, Brazil; DOr Inst Res & Educ IDOR, Postgrad Program Translat Med, Rua Diniz Cordeiro,30 3 Andar, BR-22281100 Rio De Janeiro, RJ, Brazil; Univ Fed Rio de Janeiro, Programa Posgrad Clin Med, Rio De Janeiro, Brazil
hcfmusp.citation.scopus1
hcfmusp.contributor.author-fmusphcLETICIA BARBOSA KAWANO DOURADO
hcfmusp.description.beginpage1392
hcfmusp.description.endpage1396
hcfmusp.description.issue11
hcfmusp.description.volume49
hcfmusp.origemWOS
hcfmusp.origem.dimensionspub.1164233575
hcfmusp.origem.pubmed37728739
hcfmusp.origem.scopus2-s2.0-85171573128
hcfmusp.origem.wosWOS:001070566500001
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUNITED STATESeng
hcfmusp.relation.referenceAustin S, 2014, INTENS CARE MED, V40, P342, DOI 10.1007/s00134-013-3174-7eng
hcfmusp.relation.referenceEspinoza R, 2019, J CRIT CARE, V50, P82, DOI 10.1016/j.jcrc.2018.11.024eng
hcfmusp.relation.referenceFlottorp SA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-35eng
hcfmusp.relation.referenceGeiling J, 2014, CHEST, V146, pE156S, DOI 10.1378/chest.14-0744eng
hcfmusp.relation.referenceLim C, 2021, CLIN MICROBIOL INFEC, V27, P1391, DOI 10.1016/j.cmi.2021.05.037eng
hcfmusp.relation.referenceMachado FR, 2017, LANCET INFECT DIS, V17, P1180, DOI 10.1016/S1473-3099(17)30322-5eng
hcfmusp.relation.referenceMartin-Loeches I, 2023, INTENS CARE MED, V49, P615, DOI 10.1007/s00134-023-07033-8eng
hcfmusp.relation.referenceMcLarty J, 2024, THORAX, V79, P120, DOI 10.1136/thorax-2022-219592eng
hcfmusp.relation.referenceMukonda E, 2021, J GLOB HEALTH, V11, DOI 10.7189/jogh.11.04055eng
hcfmusp.relation.referencePisani L, 2022, LANCET GLOB HEALTH, V10, pE227, DOI 10.1016/S2214-109X(21)00485-Xeng
hcfmusp.relation.referenceSchünemann HJ, 2017, J CLIN EPIDEMIOL, V81, P101, DOI 10.1016/j.jclinepi.2016.09.009eng
hcfmusp.relation.referenceShiffman Richard N, 2005, BMC Med Inform Decis Mak, V5, P23, DOI 10.1186/1472-6947-5-23eng
hcfmusp.relation.referenceTamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194eng
hcfmusp.relation.referenceVos T, 2020, LANCET, V396, P1562eng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication052d82f7-99a9-42ea-a355-a4ce915e0a64
relation.isAuthorOfPublication.latestForDiscovery052d82f7-99a9-42ea-a355-a4ce915e0a64
Arquivos